The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE-Boeing, Tyco, LDK Solar, Amazon, Starbucks

Fri, 26th Apr 2013 13:18

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s, for the Morning News Call newsletter, http://link.reuters.com/faq23t)

April 26 (Reuters) - Some U.S. stocks to watch on Friday:

FUTURES EXTEND DECLINES AFTER GDP DATA

Index futures extended declines after data showed grossdomestic product expanded at a slower-than-expected rate in thefirst quarter. S&P 500 futures fell 4.7 points. Dow Jonesindustrial average futures lost 43 points and Nasdaq 100futures dropped 9.75 points.

** PFIZER INC, Thursday close $30.26, down 3 pctpremarket

European regulators declined to approve marketing ofPfizer's new rheumatoid arthritis treatment Xeljanz, citing therisks of the drug compared with its potential benefit, thecompany said on Thursday.

** APPLE INC, Thursday close $408.38, down 0.3 pctpremarket

Samsung Electronics Co Ltd grabbed moresmartphone market share from arch rival Apple in the latestquarter, with sales of its phones jumping to account for onethird of the global market, research firm IDC said.

** BOEING CO, Friday close $91.67, up 1 pct premarket

BB&T Capital Markets upgraded Boeing shares to "buy," citingthe aerospace company's better-than-expected earnings and thenews that the U.S. Federal Aviation Administration approved thecompany's new lithium-ion battery system for the 787 Dreamliner,grounded since mid-January.

Japan Airlines Co Ltd said it aims to return theDreamliners to commercial flights in June.

** CHEVRON CORP, Thursday close $118.51, up 0.4 pctpremarket

The second-largest U.S. oil company posted a 4.5 percentdecline in quarterly profit on Friday, pinched by weaker oilprices and work at its U.S. refineries.

** AMAZON.COM INC, Thursday close $274.70, down 2.8pct premarket

Revenue growth slowed in the first quarter as the world'slargest Internet retailer struggled overseas, but margins jumpedon lower shipping expenses and the expansion of more profitablenew businesses.

** STARBUCKS CORP, Thursday close $60.50, down 2pct premarket

It reported higher quarterly profit on Thursday that matchedWall Street estimates and it raised its full-year earningsforecast. But revenue was slightly below analysts' estimates.

** TYCO INTERNATIONAL LTD, Thursday close $31.08, up4.6 pct premarket

The fire safety and security systems maker reported anadjusted quarterly profit ahead of Wall Street estimates asunderlying margins rose.

** SKYWORKS SOLUTIONS INC, Thursday close $22.02,up 2 pct premarket

Cannacord Genuity raised its target price on the company'sstock, citing higher margin analog sales in the next fewquarters. "We anticipate an increased mix of higher marginanalog sales within both the Handset and HPA businesses over thenext several quarters," Cannacord Genuity analyst MichaelWalkley said in a note. One other brokerage raised its pricetarget on the company's stock. The supplier to Apple Increported second-quarter results above analysts' expectations onThursday and forecast current-quarter adjusted profit aboveestimates.

** ABBVIE INC, Thursday close $44.24

AbbVie, the pharmaceuticals business spun off in January byAbbott Laboratories, reported slightly better thanexpected quarterly results, fueled by surging sales of itsHumira treatment for rheumatoid arthritis.

** WEYERHAEUSER CO, Thursday close $31.38, up 1.8 pctpremarket

The forest products company reported a first-quarter netprofit that more than tripled due to a recovery in the U.S.housing market, and said it expects higher volumes for all itswood products for the current quarter.

** THERAVANCE, Thursday close $30.92, up 5 pct premarket

The company plans to split into two publicly traded U.S.companies, separating some of its most advanced respiratorydrugs under development with GlaxoSmithKline Plc fromits other biopharmaceutical operations.

** USG CORP, Thursday close $26.20, down 1 pctpremarket

RBC Capital Markets cut its rating on the building productsmaker's stock to "outperform" from "top pick," and said thoughit continues to have a favorable view of the company'shigh-margin ceiling grid business, demand would remain choppy.

** D.R. HORTON INC, Thursday close $24.53, up 6 pctpremarket

** LENNAR CORP, Thursday close $41.93, up 3 pctpremarket

D.R. Horton, the No.1 U.S. home builder reported a 173percent jump in quarterly profit and said the spring sellingseason was off to a strong start. Record-low interest rates andrising rents have prompted Americans to buy homes, leading toshortage of new houses.

Homebuilder Lennar's stock was also up on the news.

** PULTEGROUP INC, Thursday close $20.79, up 1.3 pctpremarket

The No. 2 U.S. homebuilder reported a better-than-expectedquarterly profit on Thursday as its strategy of selling fewerhomes at higher prices paid off. [ID;nL3N0DC8SL]

** CIRRUS LOGIC INC, Thursday close $19.62, down 3pct premarket

The audio chipmaker on Thursday reported fourth-quarterresults above analysts' expectations, but brokerage Needham &Company cut its target price on the company's stock, citinglower revenue from Apple than "previously anticipated."

** SIMON PROPERTY GROUP, Thursday close $176.01

The biggest U.S. owner of malls and outlet centers said akey earnings measure rose 14.4 percent in the first quarter,helped by higher rents and sales at its malls and outletcenters, prompting the company to raise its forecast for theyear.

** LAZARD LTD, Thursday close $33.16

The investment bank reported a 40 percent fall infirst-quarter profit, earning less from its financial advisorybusiness in a subdued merger and acquisitions market.

** TRANSCANADA CORP , Thursday close $48.74

Canada's largest pipeline company reported a 27 percent risein first-quarter profit, and said it now expects its Keystone XLpipeline to be in service in the second half of 2015.

** BAIDU INC, Thursday close $92.34, down 9 pctpremarket

China's largest search engine will increase marketingexpenditures for the rest of the year to counter competitionfrom rival Qihoo 360 Technology, which may further putthe brakes on profit growth.

** COINSTAR INC, Thursday close $55.03, up 8.3 pctpremarket

Coinstar raised its full-year adjusted profit forecast ONThursday as it bets on a slate of movies scheduled to bereleased in the third quarter to boost its Redbox video rentalbusiness.

** PERKINELMER INC, Thursday close $34.47, down 11.5pct premarket

The maker of scientific instruments, diagnostic equipmentand environmental safety monitoring products on Thursdayreported lower-than-expected first-quarter profit and decreasedits full-year forecast as difficult economic conditions and astronger dollar hurt sales in Europe and Japan.

** ECHO GLOBAL LOGISTICS INC, Thursday close$19.08, down 5 pct premarket

The logistics company cut its 2013 earnings forecast tobetween 78 and 84 cents per share from between 82 and 90 cents,and lowered its revenue outlook to $900 million to $940 millionfrom $940 million to $980 million.

Analysts on average were expecting earnings of 85 cents pershare on revenue of $960.6 million, according to Thomson ReutersI/B/E/S.

** J.C. PENNEY CO, Thursday close $15.24, up 8 pctpremarket

Billionaire investor George Soros reported a 7.9 percentpassive stake in the struggling department store chain onThursday.

** FREESCALE SEMICONDUCTOR LTD, Thursday close$14.55, up 8 pct after market

The chipmaker reported a much smaller-than-expectedfirst-quarter loss and forecast upbeat second-quarter revenue,as demand from its Chinese customers improved.

** EXPEDIA INC, Thursday close $64.97, down 4.6 pctpremarket

The online travel agency reported a higher-than-expectedfirst-quarter adjusted profit, but warned of a lower full-yearprofit from its discount travel website Hotwire due to highercar rental rates and increased competition.

** MICROS SYSTEMS INC, Thursday close $43.52, down6.9 pct premarket

The company, which makes data management systems forretailers and hotel chains, reported much weaker-than-expectedthird-quarter results, as hardware sales grew a lacklustre 2percent and software sales declined. Micros also cut itsfull-year outlook.

** VERISIGN INC, Thursday close $46.10, up 3 pctafter market

The issue of .com and .net Internet domains names reported abetter-than expected quarterly profit as revenue rose 15percent. Excluding items, the company earned 58 cents per share,on revenue of $236 million. Analysts expected an adjusted profitof 54 cents per share and revenue of 232.6 million, according toThomson Reuters I/B/E/S.

** LDK SOLAR CO LTD, Thursday close $1.28, down 3pct premarket

The indebted Chinese solar panel maker on Friday said itwould sell 25 million shares to Fulai Investments Ltd for about$26 million to fund its operations. Fulai will pay $1.03 pershare, a discount of about 20 percent to LDK's Thursday close onthe New York Stock Exchange.

** INTERNATIONAL GAME TECHNOLOGY, Thursday close$17.30, up 2.3 pct premarket

The slot-games maker on Thursday reportedbetter-than-expected second-quarter results on higher revenuefrom its social gaming business, which more than doubled from ayear earlier. The company, whose stock touched a year-highyesterday, also raised its full-year 2013 forecast for adjustedprofit, prompting J.P. Morgan and another brokerage to raisetheir target price on the company's stock.

** ALTERA CORP, Thursday close $32.93, down 2.2 pctafter market

The programmable chipmaker posted revenue slightly belowexpectations in the first quarter and said it was beginning tosee a recovery from a dip in demand from its communications andindustrial customers.

** SYNAPTICS INC, Thursday close $38.54, up 18 pctpremarket

The touchscreen chipmaker forecast current-quarter resultsfar above analysts' estimates on Thursday and confirmed that ithad won contracts from Samsung Electronics Co Ltd for its Galaxy S4 smartphone and Note 8 tablet.

** LOGMEIN INC, Thursday close $17.86, up 20.4 pct premarket

The maker of remote-access software postedbetter-than-expected quarterly results as it won a record 37,000paying subscribers, and the company forecast second-quarterrevenue above analysts' estimates.

** INFORMATICA CORP, Thursday close $32.31, up 9pct after market

** QLIK TECHNOLOGIES INC, Thursday close $23.85, up11.1 pct premarket

The business software makers reported better-than-expectedquarterly revenue and raised their full-year revenue forecastsas enterprises spent more on integrating and analyzing data.

** CURIS INC, Thursday close $3.41, up 8 pctpremarket

** VIVUS INC, Thursday close $12.43, up 1 pctpremarket

** AVANIR PHARMACEUTICALS INC, Thursday close$3.20, up 15 pct premarket

European health regulators on Thursday recommended approvalof Roche Holdings AG's drug Erivedge to treat peoplewith advanced forms of basal cell carcinoma, the most commonskin cancer. Curis is Roche's partner on the drug and isentitled to certain payments from it.

The European Medicines Agency experts also backed Avanir'sNuedexta to treat a neurologic disorder called pseudobulbareffect, and Vivus's erectile dysfunction drug Spedra.

** KLA-TENCOR CORP, Thursday close $55.90, down 5pct after market

The chip equipment maker reported lower quarterly results onThursday and said its outlook for the rest of the year hasweakened due to manufacturers' concerns about the globaleconomy.

** HOMEX DEVELOPMENT CORP , Thursday close$7.02, down 17.8 pct premarket

The Mexican homebuilder's first-quarter profit and revenuefell sharply as it struggled with slowing home sales and arising debt load, the company said on Thursday.

** H&R BLOCK INC, Thursday close $28.03, down 3 pctpremarket

The tax preparer said its share of tax returns prepared sofar this year has remained essentially flat, compared with ayear earlier, sending its stock down 9 percent after the bell.

** FIRST MAJESTIC SILVER CORP , $12.62, up 1.4pct premarket (0810 ET)

The supreme court of British Columbia ruled in favor of thecompany which took a case against Hector Davila, the former topexecutive of First Silver Reserve Inc (FSR), the company'swholly-owned subsidiary, for violating his fiduciary duty toFSR.

The company, which commenced the litigation in November2007, alleged that while Davila held his positions at FSR heacquired the Bolanos Mine from Grupo Mexico through MineraArroyo, for his own personal interest.

** MOLINA HEALTHCARE INC, Thursday close $33.23,down 0.7 pct premarket

The health insurer reported a first-quarter profit that wasmuch above analysts' estimates, helped by a rate increase as itsCalifornia health plan and better performance at the Florida,Texas, Ohio and Wisconsin health plans, among others.

** DECKERS OUTDOOR CORP, Thursday close $59.4, down3.4 pct premarket

The shoe maker, known for its UGG boots, on Thursdayforecast a current quarter loss of about $1.10 per share.Analysts on average were expecting a loss of 96 cents per share,according to Thomson Reuters I/B/E/S.

Both Canaccord Genuity and ISI Group said investors weredisappointed with the unexpected increase in first-quarterinventories and the second-quarter guidance. (Compiled by Sruthi Ramakrishnan in Bangalore; Editing byJoyjeet Das)

More News
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.